The novel treatment of tirzepatide peptide represents a significant development in the care of the condition. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide155605.bloguetechno.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-78725650